Profile - To The Moon

Kiyosumi

Posts · 65Posts · 65
Following · 0Following · 0
Followers · 0Followers · 0

- KiyosumiKiyosumi
  ·08-28
  $Tiger Brokers(TIGR)$ only loser shorties sell. Winners hold long
  1.22K Comment
  3
  Share
  Report
- KiyosumiKiyosumi
  ·08-06
  I vote for interest life as it is the cutest and earning money helps us pursue our interests!
  957 Comment
  1
  Share
  Report
- KiyosumiKiyosumi
  ·06-17
  These retards don't know what they are saying. Nvax is the ONLY non MRNA vaccine for covid. MRNA is the problem. And did they even read the Q1 2025 results? Bloody shorties making rubbish claims to make people sell.
  BUZZ-Citi starts Novavax with "sell/high risk" rating on shrinking vaccine market
  BUZZ-Citi starts Novavax with "sell/high risk" rating on shrinking vaccine market** Brokerage Citi Research starts coverage on vaccine maker Novavax NVAX.O with "sell/high risk" rating and $6 PT** PT
  BUZZ-Citi starts Novavax with "sell/high risk" rating on shrinking vaccine market
  1.38K Comment
  1
  Share
  Report
- KiyosumiKiyosumi
  ·06-12
  $Asana, Inc.(ASAN)$ why yall selling at such low prices stop selling. BUY BUY BUY
  1.40K Comment
  2
  Share
  Report
- KiyosumiKiyosumi
  ·06-12
  $Joby Aviation, Inc.(JOBY)$ $Archer Aviation Inc.(ACHR)$ Best stocks to buy now. They should go up by a dollar within this week due to Trump's executive order
  3.24K Comment
  4
  Share
  Report
- KiyosumiKiyosumi
  ·06-03
  $Novavax(NVAX)$ GO AND BUY
  1.18K Comment
  1
  Share
  Report
- KiyosumiKiyosumi
  ·05-21
  $Novavax(NVAX)$ easy money
  1.37K Comment
  1
  Share
  Report
- KiyosumiKiyosumi
  ·04-10
  $Strategy(MSTR)$ ez money
  1.55K Comment
  1
  Share
  Report
- KiyosumiKiyosumi
  ·04-08
  I love the mug slogan. Voted for it
  1.76K Comment
  1
  Share
  Report
- KiyosumiKiyosumi
  ·04-06
  $Bitwise Crypto Industry Innovators ETF(BITQ)$ ez free money
  1.85K 1
  2
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3577571037224614","uuid":"3577571037224614","gmtCreate":1614477503284,"gmtModify":1614741435607,"name":"Kiyosumi","pinyin":"kiyosumi","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":11,"headSize":62,"tweetSize":65,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.08","exceedPercentage":"93.64%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.07","exceedPercentage":"93.94%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":5,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":472282352963856,"gmtCreate":1756339000671,"gmtModify":1756345562458,"author":{"id":"3577571037224614","authorId":"3577571037224614","name":"Kiyosumi","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3577571037224614","idStr":"3577571037224614"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ </a> only loser shorties sell. Winners hold long&nbsp;","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ </a> only loser shorties sell. Winners hold long&nbsp;","text":"$Tiger Brokers(TIGR)$ only loser shorties sell. Winners hold long","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/472282352963856","isVote":1,"tweetType":1,"viewCount":1218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":464683952984152,"gmtCreate":1754439193480,"gmtModify":1754439197486,"author":{"id":"3577571037224614","authorId":"3577571037224614","name":"Kiyosumi","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3577571037224614","idStr":"3577571037224614"},"themes":[],"htmlText":"I vote for interest life as it is the cutest and earning money helps us pursue our interests!","listText":"I vote for interest life as it is the cutest and earning money helps us pursue our interests!","text":"I vote for interest life as it is the cutest and earning money helps us pursue our interests!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/464683952984152","isVote":1,"tweetType":1,"viewCount":957,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":447097741525344,"gmtCreate":1750161664620,"gmtModify":1750165888254,"author":{"id":"3577571037224614","authorId":"3577571037224614","name":"Kiyosumi","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3577571037224614","idStr":"3577571037224614"},"themes":[],"htmlText":"These retards don't know what they are saying. Nvax is the ONLY non MRNA vaccine for covid. MRNA is the problem. And did they even read the Q1 2025 results? Bloody shorties making rubbish claims to make people sell.&nbsp;","listText":"These retards don't know what they are saying. Nvax is the ONLY non MRNA vaccine for covid. MRNA is the problem. And did they even read the Q1 2025 results? Bloody shorties making rubbish claims to make people sell.&nbsp;","text":"These retards don't know what they are saying. Nvax is the ONLY non MRNA vaccine for covid. MRNA is the problem. And did they even read the Q1 2025 results? Bloody shorties making rubbish claims to make people sell.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/447097741525344","repostId":"2544964382","repostType":2,"repost":{"id":"2544964382","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1750160347,"share":"https://ttm.financial/m/news/2544964382?lang=&edition=fundamental","pubTime":"2025-06-17 19:39","market":"us","language":"en","title":"BUZZ-Citi starts Novavax with \"sell/high risk\" rating on shrinking vaccine market","url":"https://stock-news.laohu8.com/highlight/detail?id=2544964382","media":"Reuters","summary":"BUZZ-Citi starts Novavax with \"sell/high risk\" rating on shrinking vaccine market** Brokerage Citi Research starts coverage on vaccine maker Novavax NVAX.O with \"sell/high risk\" rating and $6 PT** PT ","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Citi starts Novavax with \"sell/high risk\" rating on shrinking vaccine market</title></head><body><p>** Brokerage Citi Research starts coverage on vaccine maker Novavax <span>NVAX.O</span> with \"sell/high risk\" rating and $6 PT</p><p>** PT represents a near 15% downside to the stock's last close</p><p>** Brokerage says Novavax is too focused on respiratory vaccines, a market that's seeing declining vaccination rates</p><p>** The COVID-19 vaccine market is shrinking yearly (10% decline overall, 12% decline in under-65 segment), brokerage says </p><p>** Brokerage also flags competition for NVAX in the respiratory vaccine space from established players such as Pfizer <span>PFE.N</span>, Moderna <span>MRNA.O</span> and GSK <span>GSK.L</span> </p><p>** Brokerage raises concerns for NVAX since FDA approved Novavax's COVID vaccine (Nuvaxovid) only for adults 65+ and high-risk individuals 12-64 years old, unlike Pfizer and Moderna vaccines which don't face these restrictions</p><p>** \"We think this is worthwhile noting, given it provides perhaps the first concrete example of Robert Kennedy Jr’s/Marty Makary's FDA and its views on COVID vaccination\" - Citi Research </p><p>** As of last close, NVAX stock down 12.6% YTD  </p><p> (Reporting by Padmanabhan Ananthan)</p><p> ((Padmanabhan.Ananthan@thomsonreuters.com))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Citi starts Novavax with \"sell/high risk\" rating on shrinking vaccine market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Citi starts Novavax with \"sell/high risk\" rating on shrinking vaccine market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-17 19:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Citi starts Novavax with \"sell/high risk\" rating on shrinking vaccine market</title></head><body><p>** Brokerage Citi Research starts coverage on vaccine maker Novavax <span>NVAX.O</span> with \"sell/high risk\" rating and $6 PT</p><p>** PT represents a near 15% downside to the stock's last close</p><p>** Brokerage says Novavax is too focused on respiratory vaccines, a market that's seeing declining vaccination rates</p><p>** The COVID-19 vaccine market is shrinking yearly (10% decline overall, 12% decline in under-65 segment), brokerage says </p><p>** Brokerage also flags competition for NVAX in the respiratory vaccine space from established players such as Pfizer <span>PFE.N</span>, Moderna <span>MRNA.O</span> and GSK <span>GSK.L</span> </p><p>** Brokerage raises concerns for NVAX since FDA approved Novavax's COVID vaccine (Nuvaxovid) only for adults 65+ and high-risk individuals 12-64 years old, unlike Pfizer and Moderna vaccines which don't face these restrictions</p><p>** \"We think this is worthwhile noting, given it provides perhaps the first concrete example of Robert Kennedy Jr’s/Marty Makary's FDA and its views on COVID vaccination\" - Citi Research </p><p>** As of last close, NVAX stock down 12.6% YTD  </p><p> (Reporting by Padmanabhan Ananthan)</p><p> ((Padmanabhan.Ananthan@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","GSK.UK":"葛兰素史克"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nL6N3SK0K4:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2544964382","content_text":"BUZZ-Citi starts Novavax with \"sell/high risk\" rating on shrinking vaccine market** Brokerage Citi Research starts coverage on vaccine maker Novavax NVAX.O with \"sell/high risk\" rating and $6 PT** PT represents a near 15% downside to the stock's last close** Brokerage says Novavax is too focused on respiratory vaccines, a market that's seeing declining vaccination rates** The COVID-19 vaccine market is shrinking yearly (10% decline overall, 12% decline in under-65 segment), brokerage says ** Brokerage also flags competition for NVAX in the respiratory vaccine space from established players such as Pfizer PFE.N, Moderna MRNA.O and GSK GSK.L ** Brokerage raises concerns for NVAX since FDA approved Novavax's COVID vaccine (Nuvaxovid) only for adults 65+ and high-risk individuals 12-64 years old, unlike Pfizer and Moderna vaccines which don't face these restrictions** \"We think this is worthwhile noting, given it provides perhaps the first concrete example of Robert Kennedy Jr’s/Marty Makary's FDA and its views on COVID vaccination\" - Citi Research ** As of last close, NVAX stock down 12.6% YTD   (Reporting by Padmanabhan Ananthan) ((Padmanabhan.Ananthan@thomsonreuters.com))","news_type":1,"symbols_score_info":{"NVAX":0.9,"GSK.UK":0.9}},"isVote":1,"tweetType":1,"viewCount":1384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":445235166396976,"gmtCreate":1749723932178,"gmtModify":1749723935344,"author":{"id":"3577571037224614","authorId":"3577571037224614","name":"Kiyosumi","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3577571037224614","idStr":"3577571037224614"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ASAN\">$Asana, Inc.(ASAN)$ </a> why yall selling at such low prices stop selling. BUY BUY&nbsp; BUY","listText":"<a href=\"https://ttm.financial/S/ASAN\">$Asana, Inc.(ASAN)$ </a> why yall selling at such low prices stop selling. BUY BUY&nbsp; BUY","text":"$Asana, Inc.(ASAN)$ why yall selling at such low prices stop selling. BUY BUY BUY","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/445235166396976","isVote":1,"tweetType":1,"viewCount":1399,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":445101370937824,"gmtCreate":1749693061076,"gmtModify":1749693273619,"author":{"id":"3577571037224614","authorId":"3577571037224614","name":"Kiyosumi","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3577571037224614","idStr":"3577571037224614"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/JOBY\">$Joby Aviation, Inc.(JOBY)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/ACHR\">$Archer Aviation Inc.(ACHR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Best stocks to buy now. They should go&nbsp;up by a dollar within this week due to Trump's executive order","listText":"<a href=\"https://ttm.financial/S/JOBY\">$Joby Aviation, Inc.(JOBY)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/ACHR\">$Archer Aviation Inc.(ACHR)$&nbsp;</a><v-v data-views=\"1\"></v-v> Best stocks to buy now. They should go&nbsp;up by a dollar within this week due to Trump's executive order","text":"$Joby Aviation, Inc.(JOBY)$ $Archer Aviation Inc.(ACHR)$ Best stocks to buy now. They should go up by a dollar within this week due to Trump's executive order","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/445101370937824","isVote":1,"tweetType":1,"viewCount":3236,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":442087035449880,"gmtCreate":1748954172960,"gmtModify":1748954175919,"author":{"id":"3577571037224614","authorId":"3577571037224614","name":"Kiyosumi","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3577571037224614","idStr":"3577571037224614"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$&nbsp;</a><v-v data-views=\"1\"></v-v> GO AND BUY","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$&nbsp;</a><v-v data-views=\"1\"></v-v> GO AND BUY","text":"$Novavax(NVAX)$ GO AND BUY","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/442087035449880","isVote":1,"tweetType":1,"viewCount":1179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":437663395836176,"gmtCreate":1747818823007,"gmtModify":1747821565733,"author":{"id":"3577571037224614","authorId":"3577571037224614","name":"Kiyosumi","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3577571037224614","idStr":"3577571037224614"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a> easy money","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$ </a> easy money","text":"$Novavax(NVAX)$ easy money","images":[{"img":"https://community-static.tradeup.com/news/0c0d05dc5bedcdb107435b00853bad94","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/437663395836176","isVote":1,"tweetType":1,"viewCount":1371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":422976065995104,"gmtCreate":1744293259780,"gmtModify":1744293264686,"author":{"id":"3577571037224614","authorId":"3577571037224614","name":"Kiyosumi","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3577571037224614","idStr":"3577571037224614"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/MSTR\">$Strategy(MSTR)$ </a> ez money","listText":"<a href=\"https://ttm.financial/S/MSTR\">$Strategy(MSTR)$ </a> ez money","text":"$Strategy(MSTR)$ ez money","images":[{"img":"https://community-static.tradeup.com/news/f48e9198dac00d10911298e9c3186dcd","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/422976065995104","isVote":1,"tweetType":1,"viewCount":1552,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":422164685484464,"gmtCreate":1744088274329,"gmtModify":1744088277961,"author":{"id":"3577571037224614","authorId":"3577571037224614","name":"Kiyosumi","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3577571037224614","idStr":"3577571037224614"},"themes":[],"htmlText":"I love the mug slogan. Voted for it","listText":"I love the mug slogan. Voted for it","text":"I love the mug slogan. Voted for it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/422164685484464","isVote":1,"tweetType":1,"viewCount":1762,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":421508120797360,"gmtCreate":1743912675203,"gmtModify":1743912679205,"author":{"id":"3577571037224614","authorId":"3577571037224614","name":"Kiyosumi","avatar":"https://static.tigerbbs.com/a6100ff043120d72f836b02093a9e5d3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3577571037224614","idStr":"3577571037224614"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BITQ\">$Bitwise Crypto Industry Innovators ETF(BITQ)$ </a> ez free money&nbsp;","listText":"<a href=\"https://ttm.financial/S/BITQ\">$Bitwise Crypto Industry Innovators ETF(BITQ)$ </a> ez free money&nbsp;","text":"$Bitwise Crypto Industry Innovators ETF(BITQ)$ ez free money","images":[{"img":"https://community-static.tradeup.com/news/ddc8113de275a6db78c04febb7a464a1","width":"882","height":"1668"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/421508120797360","isVote":1,"tweetType":1,"viewCount":1852,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583377018896117","authorId":"3583377018896117","name":"bernardtayet","avatar":"https://static.tigerbbs.com/43e8c1fc37a4bff2a94af98953cff267","crmLevel":12,"crmLevelSwitch":1,"authorIdStr":"3583377018896117","idStr":"3583377018896117"},"content":"Bitcoin money coming in quick. Great foresight.","text":"Bitcoin money coming in quick. Great foresight.","html":"Bitcoin money coming in quick. Great foresight."}],"imageCount":1,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}